Flexzo AI Raises $12M Series A for Agentic Staffing

Flexzo AI raised $12M Series A led by Octopus Ventures for agentic AI healthcare staffing. Targets NHS Trusts to cut agency spend 30%+ via zero-fee internal banks and US expansion.

Emel Kavaloglu

Flexzo AI, a UK-based AI-powered healthcare staffing platform, has raised $12M in Series A funding led by Octopus Ventures with participation from Fuel Ventures. The platform connects NHS Trusts directly with pre-vetted, compliance-ready professionals via agentic AI to automate shift fulfillment and reduce agency spend. The capital will support wider adoption across UK NHS Trusts and accelerate expansion into the US.

NHS Mandates 30% Agency Cuts

The round times with NHS England's mandate for a 30% reduction in agency spend by 2026/27 (NHS England). Locum's Nest raised $8M for its mobile locum marketplace. Flexzo differentiates with fully autonomous AI that identifies gaps, validates compliance, and routes to internal banks without human intervention or agency fees.

Agency Spend Hits £3B Mark

The NHS faces over 113,000 vacancies and spent £3 billion on agency staff in 2023/24, with fees reaching £2,000 per nursing shift. Current solutions rely on manual marketplaces or agencies, leaving 25-40% of costs in fees. Agency spend dropped £1B in 2024/25 after crackdowns, but mandates demand further cuts (Gov.uk).

Agentic AI Drives Internal Fills

Flexzo's agentic AI system autonomously fills shifts from internal banks, national pools, and collaborative networks, claiming 60% uplift in internal fill rates and 35% agency spend reduction. Products like Internal Staff Bank and Clinical Services Planner provide real-time compliance audits and predictive planning. Unlike Locum's Nest's manual matching or Tempally's agency tools, Flexzo targets net-zero agency costs via subscription model paying clinician rates only.

As Jack Henderson, CEO and Founder, noted:

"The way healthcare organisations manage their workforce hasn’t fundamentally changed in decades. Until now. Hospitals shouldn’t be forced to rely on inefficient processes and spiralling agency costs. With Flexzo AI, we’re delivering the step change in efficiency the system urgently needs."

Octopus Validates NHS ROI

Octopus Ventures leads with conviction in Flexzo's proven ROI across NHS Trusts, including 85% agency spend cuts and over 65% external shift fills (UKTN). Fuel Ventures, prior seed investor with £5M total, doubles down for US scale. This mix signals growth capital for international proof beyond UK.

As Uthish Ranjan, Octopus Ventures partner, noted:

"The strong ROI impact already delivered across NHS Trusts – alongside early traction in the US – demonstrates both the urgency of the problem and the strength of the product."

UK Staffing Market Scales to $7.5B

The UK healthcare staffing market stands at $3.25B in 2025, projected to reach $7.52B by 2035 at 8.7% CAGR (Grand View Research). Broader workforce management grows at 13.2% CAGR. Trends favor AI automation amid productivity mandates and digital staff banks.

Founder Scales Prior Exit

CEO Jack Henderson bootstrapped KPI:Health to £20M annualized revenue and £1M+ EBITDA before a successful exit, without external capital (LinkedIn). His decade in medical recruitment and NHS insourcing directly informs Flexzo's compliance-first platform. Recent addition of Professor Rupert Shute as Chairman brings government advisory expertise.

US Launch Partners Florida Clinics

Flexzo launched in the US with a multi-year partnership deploying across Island Doctors' Florida clinics (Yahoo Finance). Plans target primary care expansion with automated compliance and shift matching. Active NHS Trust listings from Oxford University Hospitals and others signal domestic momentum.

TAMradar monitors companies, people, and industries so you never miss important updates - tracking funding rounds, new hires, job openings, and 20+ signals.

Request access to get insights like this via webhooks or email.

Request access →

Index